As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
Designing for Access: Addressing Pharmacy Deserts with Flexible Solutions
Baylor Scott & White Health Set to Open New Texas Medical Center 
The Future of Backup Power Systems in Healthcare Facilities
Infection Control is Key to Ongoing Measles Outbreak
Kaiser Permanente to Open New Parker Medical Offices